ECM Weekly (3 November 2018) - TFFIF, Innovent, Softbank, Zhaogang - Open the IPO Floodgate!
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
484 Views
Innovent Biologics (信达生物) Post IPO: Hit Our TP, What's Next?
Innovent Biologics was priced at the high end and it started trading yesterday (November 1st). It traded up by 18.5% on the first day and 8% on the...
541 Views
Innovent Biologics IPO First-Day: Take Money off the Table
Despite a recent spell of lacklustre early-stage biotech flotations that have slumped post-IPO, Innovent Biologics Inc (1801 HK)'s shares popped...
521 Views
Last Week in GER Research: Tencent Backed IPOs, Niu, Innovent Biologics, Babytree and Fujifilm
Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team. This week we highlight a very differentiated...
658 Views
Innovent Biologics (信达生物) IPO: Limited Upside Despite Strong Cornerstones (Part 3)
Innovent Biologics launched the institutional book building today and intends to raise USD 377 to USD 423 million, with an implied market...
414 Views